News
Amgen Inc. (NASDAQ:AMGN) is one of the 10 Best Value Stocks to Buy According to Billionaires. On June 23, the company ...
Amgen Inc. (NASDAQ:AMGN) ranks among the best set-it-and-forget-it stocks to buy. On June 24, Piper Sandler reaffirmed its ...
MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...
Amgen Inc. (NASDAQ: AMGN) is one of the 10 Best Value Stocks to Buy According to Billionaires. On June 23, the company announced full results from Part 1 of the Phase 2 study of MariTide ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
MariTide (maridebart cafraglutide; previously AMG 133) has emerged as one of Amgen's most promising pipeline projects thanks to its potential to offer once-monthly or even less frequent dosing, in ...
Both well-established and small, clinical-stage pharma companies are investing heavily to be able to someday compete with ...
ADA 2025 Once-Monthly MariTide Promising in Phase 2 Despite GI Issues Patients with obesity, with or without diabetes, lose up to 20% body weight and show A1c reductions with the novel agent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results